STEMI Rapid Reperfusion Urgency Assessment Tool

Clinical calculation support · Verify results before clinical use

Clinical decision support
Use this assessment to support rapid reperfusion planning in a patient with a working diagnosis of STEMI. It does not replace ECG confirmation, contraindication screening, local STEMI protocols, or immediate clinician judgement. Do not delay activation or transfer to complete this form.

Patient and system factors

Enter estimated time intervals and current clinical status.

REPERFUSION PATHWAY
Where is the patient currently being assessed?
Use elapsed time from symptom onset to first medical contact.
Estimate the full system delay, including transfer if required.
For eligible patients receiving fibrinolysis, minimize delay; a ≤30-minute target is commonly used in hospital pathways.
Requires a formal contraindication screen before any fibrinolytic is given.
Choose “present” if any listed feature is present.

Clinical context

For STEMI with symptom onset within 12 hours, primary PCI is preferred when it can be delivered within the recommended system delay. At a non-PCI-capable hospital, transfer for primary PCI is recommended when FMC-to-device time can be achieved within 120 minutes. If the anticipated delay exceeds 120 minutes, fibrinolysis should be considered promptly in eligible patients without contraindications, followed by immediate transfer to a PCI-capable centre.

For patients presenting 12–24 hours after symptom onset, transfer for primary PCI is reasonable. In presentations beyond 24 hours, routine PCI of a persistently occluded infarct-related artery is not recommended solely on the basis of the occlusion in otherwise stable patients; ongoing ischemia, shock, acute severe heart failure, or life-threatening arrhythmia changes the urgency and requires emergency specialist assessment.

Important implementation notes

  • The 90-minute target is a common system goal for direct presentation; the key decision threshold for timely primary PCI in this pathway is generally 120 minutes.
  • Door-to-needle time is displayed for planning and quality monitoring; it should not determine whether fibrinolysis is clinically indicated.
  • After fibrinolysis, transfer to a PCI-capable centre is required. Failed fibrinolysis or clinical deterioration calls for urgent rescue PCI assessment.
  • This simplified tool does not assess ECG criteria, infarct territory, bleeding risk details, individual fibrinolysis contraindications, or the full differential diagnosis.

References

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes.Circulation. 2025. doi:10.1161/CIR.0000000000001309
2023 ESC Guidelines for the management of acute coronary syndromes.European Heart Journal. 2023. doi:10.1093/eurheartj/ehad191
Disclaimer: This tool provides educational clinical decision support and does not replace clinical judgement, ECG interpretation, assessment of contraindications, consultation with cardiology, or local emergency protocols. Suspected STEMI is time-critical. Activate the appropriate reperfusion pathway immediately and do not delay care to use this tool.